4 completed. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow Ligand Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy Intravenous Carbamazepine (IV CBZ) - Epilepsy | Phase 3 | Completed | Lundbeck LLC | 108 | 2010-06-01 | 2018-01-16 |
| Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata Targretin Gel 1% - Alopecia Areata | Phase 2 / Phase 3 | Completed | M.D. Anderson Cancer Center | 46 | 2003-05-01 | 2012-08-02 |
| Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss lasofoxifene, raloxifene, Placebo - Osteoporosis | Phase 3 | Completed | Ligand Pharmaceuticals | 540 | 2003-05-01 | 2011-08-12 |
| Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL) lasofoxifene, placebo - Osteoporosis | Phase 3 | Completed | Ligand Pharmaceuticals | 8556 | 2001-11-01 | 2011-08-15 |
Osteoporosis (2) · Alopecia Areata (1) · Alopecia universalis (1) · Epilepsy (1)
Lasofoxifene (2) · Bexarotene (1) · Carbamazepine (1) · Raloxifene Hydrochloride (1)
United States (4) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Canada (1) · Costa Rica (1) · Croatia (1) · Denmark (1) · Egypt (1) · Estonia (1) · Finland (1) · France (1) · Germany (1) · Hong Kong (1)